| 股票 | 富途行业 | PE | PB | 股息率 | 分红率 | 毛利率 | ROE | 固定资产 | 负债率 | OCF/市值 | 营收增速 | 利润增速 | 近60日 | YTD | 近一年 | 距52周高 | 市值亿 ▴ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 奥星生命科技 06118 | 生物技术 | 17.9 | 0.37 | 0.0% | 0% | 19% | 4% | 15% | 61% | 29.0% | +7% | +153% | -8% | -20% | -44% | 44% | 4 |
| 迈博药业-B 02181 | 生物技术 | 18.5 | 8.24 | 0.0% | 0% | 89% | 47% | 49% | 86% | 6.4% | +162% | +147% | +20% | -11% | -39% | 54% | 18 |
| 方达控股 01521 | 生物技术 | 31.6 | 0.95 | 0.0% | 0% | 27% | 2% | 23% | 36% | 7.4% | +1% | +994% | +41% | +30% | -6% | 86% | 26 |
| 维亚生物 01873 | 生物技术 | 13.6 | 0.61 | 0.0% | 0% | 38% | 6% | 18% | 44% | 18.5% | -9% | +27% | +16% | -26% | -43% | 41% | 28 |
| 和铂医药-B 02142 | 生物技术 | 19.3 | 3.90 | 0.0% | 0% | 94% | 37% | 1% | 27% | 1.2% | +315% | +3270% | +48% | +21% | +16% | 82% | 128 |
| 昭衍新药 06127 | 生物技术 | 15.0 | 1.65 | 0.6% | 9% | 17% | 4% | 15% | 14% | 1.8% | -14% | +346% | +39% | +11% | +13% | 76% | 170 |
| 百奥赛图-B 02315 | 生物技术 | 64.2 | 9.71 | 0.0% | 0% | 76% | 12% | 44% | 42% | 1.8% | +47% | +440% | +52% | +72% | +190% | 80% | 271 |
| 诺诚健华 09969 | 生物技术 | 25.7 | 3.07 | 0.0% | 0% | 92% | 9% | 8% | 28% | 0.6% | +146% | +249% | +48% | +25% | -9% | 76% | 272 |
| 药明合联 02268 | 生物技术 | 51.6 | 7.10 | 0.0% | 0% | 36% | 17% | 29% | 26% | 1.4% | +53% | +45% | +57% | +20% | +36% | 85% | 923 |
| 药明生物 02269 | 生物技术 | 35.4 | 3.69 | 0.0% | 0% | 46% | 11% | 45% | 17% | 2.5% | +22% | +52% | +66% | +56% | +58% | 90% | 2042 |
| 百济神州 06160 | 生物技术 | 66.2 | 8.39 | 0.0% | 0% | 88% | 8% | 23% | 47% | 3.4% | +40% | +145% | +36% | +23% | +25% | 94% | 3405 |
| 药明康德 02359 | 生物技术 | 22.6 | 5.96 | 1.2% | 28% | 47% | 28% | 28% | 22% | 3.7% | +21% | +114% | +60% | +98% | +94% | 90% | 5716 |
点表头排序。市值单位亿港元;财务为最近年报(futu 筛选器);分红率 = 股息率 × PE;OCF/市值 = 经营现金流 ÷ 市值(无 FCF);距52周高 = 现价 / 52 周最高。